GCA
Gradient Capital Advisors Portfolio holdings
AUM
$339M
This Quarter Return
+1.26%
1 Year Return
+15.68%
3 Year Return
+57.01%
5 Year Return
+90.28%
10 Year Return
–
AUM
$310M
AUM Growth
+$310M
(+2.7%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
9.55%
Top 10 Holdings %
Top 10 Hldgs %
39.99%
Holding
154
New
6
Increased
71
Reduced
57
Closed
2
Top Buys
| 1 |
Schwab US Mid-Cap ETF
SCHM
|
$5.62M |
| 2 |
Schwab International Equity ETF
SCHF
|
$4.51M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
$4.33M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
$2.37M |
| 5 |
Lam Research
LRCX
|
$1.49M |
Top Sells
| 1 |
Apple
AAPL
|
$474K |
| 2 |
Vanguard Ultra-Short Bond ETF
VUSB
|
$256K |
| 3 |
Vanguard International High Dividend Yield ETF
VYMI
|
$247K |
| 4 |
iShares Biotechnology ETF
IBB
|
$209K |
| 5 |
JPMorgan Chase
JPM
|
$200K |
Sector Composition
| 1 | Technology | 13.1% |
| 2 | Consumer Discretionary | 4.43% |
| 3 | Financials | 4.22% |
| 4 | Communication Services | 3.03% |
| 5 | Healthcare | 1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Bristol-Myers Squibb
BMY
$96.5B
| $201K | 0.06% |
+3,549
| New | +$201K |
|
152
Immunoprecise Antibodies
IPA
$89.1M
| $11K | ﹤0.01% |
26,808
| – | – |
|
|
153
iShares Biotechnology ETF
IBB
$5.69B
| – | – |
-1,434
| Closed | -$209K |
|
|
154
Vanguard International High Dividend Yield ETF
VYMI
$11.7B
| – | – |
-3,368
| Closed | -$247K |
|